Compare Definium Therapeutics Inc. Common Shares (DFTX) vs Hut 8 Corp (HUT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs Hut 8 Corp — how do they compare? Definium Therapeutics Inc. Common Shares trades at $35.95 (market cap $4.71B), while Hut 8 Corp trades at $81.86 (market cap $11.01B). The key difference: Hut 8 Corp is far larger — about 2.3× Definium Therapeutics Inc. Common Shares's market cap, and Definium Therapeutics Inc. Common Shares is trading nearer its 52-week high, Hut 8 Corp nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Hut 8 Corp for 11 Days on average.
| DFTX | HUT | |
|---|---|---|
Market Cap | $4.71B | $11.01B |
Volume | 1,966,636 | 9,892,615 |
Sector | Health | Financials |
52-Week High | $48.45 | $133.02 |
52-Week Low | $10.68 | $33.76 |
Typical Hold Time | 0 Days | 11 Days |
Enterprise Value | $3.67B | $18.45B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
HUT trades at $89.30, down 3.17% today, with a bearish technical signal and negative earnings momentum. The company reported significant losses with a net income margin of -188.59% despite revenue growth projections. Recent developments include a $1.07 billion credit facility expansion and strong analyst support with 93.75% buy ratings and a $156.79 consensus price target, suggesting substantial upside potential from current levels.
While HUT faces fundamental challenges with persistent losses and negative cash flow, the company's strategic pivot to AI infrastructure and substantial contract pipeline ($26.6B in long-term contracts) offers growth potential. Key risks include execution challenges in transitioning from mining operations and competitive pressures in the rapidly evolving AI infrastructure space. The stock presents a high-risk, high-reward opportunity with significant analyst optimism.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About Hut 8 Corp
Hut 8 is one of North America's largest digital asset miners and infrastructure providers. It operates diversified data centers supporting Bitcoin mining and high-performance computing (HPC) for AI.
Read more on HUT →
